For unrelated study purposes [20], these ER-positive tumor samples had been preselected from two different age-at-onset breast cancer case populations (young, ≤ age 45; older, ≥ 70), but were otherwise indistinguishable with regard to standard prognostic markers and systemic adjuvant therapy including TAM. The gene discussed is ESR1; the disease is breast cancer.